Get the Stockscreener App
83.54
1.83%
1.50
Pre-market:
83.80
0.26
+0.31%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ventas Inc stock is traded at $83.54, with a volume of 4.81M.
It is up +1.83% in the last 24 hours and down -7.17% over the past month.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
See More
Previous Close:
$82.04
Open:
$82.06
24h Volume:
4.81M
Relative Volume:
1.18
Market Cap:
$42.85B
Revenue:
$6.13B
Net Income/Loss:
$272.21M
P/E Ratio:
151.31
EPS:
0.5521
Net Cash Flow:
$1.38B
1W Performance:
+2.05%
1M Performance:
-7.17%
6M Performance:
-1.03%
1Y Performance:
+23.85%
1-Day Range:
$0.00
$0.00
1-Week Range:
$79.85
$83.56
52-Week Range:
$66.92
$101.60
Ventas Inc Stock (VTR) Company Profile
Name
Ventas Inc
Sector
Industry
Phone
(312) 660-3800
Address
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, OHI, DOC, AHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
83.54 | 42.85B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
230.29 | 165.94B | 11.75B | 1.46B | 2.19B | -0.6014 |
OHI
Omega Healthcare Investors Inc
|
45.17 | 13.69B | 1.24B | 655.98M | 857.80M | 2.063 |
DOC
Healthpeak Properties Inc
|
18.95 | 13.07B | 2.87B | 250.10M | 1.13B | 0.3188 |
AHR
American Healthcare Reit Inc
|
52.52 | 11.45B | 2.37B | 101.67M | 169.19M | 0.5775 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-26 | Resumed | Jefferies | Buy |
| Jul-07-26 | Initiated | Barclays | Equal Weight |
| Jun-17-26 | Resumed | Raymond James | Outperform |
| Jan-09-26 | Initiated | Goldman | Buy |
| Oct-01-25 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-19-25 | Initiated | UBS | Neutral |
| Jun-23-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-07-25 | Upgrade | Argus | Hold → Buy |
| Jan-17-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-01-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-26-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-30-24 | Initiated | Deutsche Bank | Buy |
| Jan-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-07-23 | Upgrade | Wedbush | Neutral → Outperform |
| Oct-11-23 | Initiated | Exane BNP Paribas | Outperform |
| Oct-03-23 | Initiated | Wedbush | Neutral |
| Sep-20-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-11-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-23-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-20-23 | Initiated | Wells Fargo | Overweight |
| Nov-01-22 | Reiterated | Credit Suisse | Outperform |
| Nov-01-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-10-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-30-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-23-22 | Initiated | Credit Suisse | Outperform |
| Jun-03-22 | Initiated | CapitalOne | Overweight |
| May-18-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-11-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Mar-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-01-22 | Initiated | Credit Suisse | Neutral |
| Jan-20-22 | Upgrade | Mizuho | Neutral → Buy |
| Dec-14-21 | Upgrade | Citigroup | Neutral → Buy |
| Nov-22-21 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Oct-04-21 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-23-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-07-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-26-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Jul-14-21 | Resumed | Mizuho | Neutral |
| Jun-15-21 | Initiated | Wolfe Research | Outperform |
| Jun-11-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-13-21 | Upgrade | KeyBanc Capital Markets | Underweight → Overweight |
| May-13-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-08-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jan-06-21 | Initiated | Robert W. Baird | Neutral |
| Nov-30-20 | Upgrade | BofA Securities | Underperform → Buy |
| Nov-10-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Argus | Buy → Hold |
| Sep-02-20 | Resumed | Stifel | Hold |
| Aug-20-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-14-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-14-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-15-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Mar-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Mar-23-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Mar-10-20 | Downgrade | Jefferies | Buy → Underperform |
| Feb-28-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jan-22-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-17-20 | Upgrade | Jefferies | Hold → Buy |
| Dec-20-19 | Resumed | Mizuho | Neutral |
| Dec-10-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Nov-19-19 | Upgrade | Argus | Hold → Buy |
| Oct-30-19 | Downgrade | Stifel | Buy → Hold |
| Oct-28-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Oct-28-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Ventas Inc Stock (VTR) Latest News
Ventas, Inc. (VTR) Stock forecasts - Yahoo Finance UK
Director Roxanne M. Martino Acquires 18.324 Shares of Ventas Through Fee Deferral Plan - Kalkine Media
Ventas Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Form 4 Ventas Inc For: 7 October By Investing.com - Investing.com UK
In lieu of director fees, Maurice S. Smith receives 18 stock units from Ventas (VTR). - Stock Titan
Director fees become 18 stock units for Ventas (VTR) director Roxanne M. Martino. - Stock Titan
Six common shares are held directly by Ventas (VTR) accounting chief Sayed Laurida. - Stock Titan
502,287 Shares in Ventas, Inc. $VTR Purchased by Congress Asset Management Co. - MarketBeat
Why Ventas (VTR) is a Great Dividend Stock Right Now - Yahoo Finance
Why Ventas (VTR) is a Great Dividend Stock Right Now - Zacks Investment Research
Evercore ISI cuts target for Ventas stock from USD 101.00 to USD 100.00 - AD HOC NEWS
Ventas Inc (VTR) Shares Fall 3.1% -- What GF Score of 74 Tells I - GuruFocus
Ventas, Inc. (VTR) Stock Forecasts - Yahoo Finance
Ventas (VTR) Stock Could Be Undervalued Following Its 118% Three Year Run - Simply Wall Street
Ventas slips as REIT rate pressure and ex-dividend trading likely weigh on shares - Quiver Quantitative
Ventas Inc. stock underperforms Monday when compared to competitors - MarketWatch
In lieu of director fees, Maurice S. Smith receives 478 stock units from Ventas (VTR). - Stock Titan
A 373-share grant replaces director fees for Sumit Roy at Ventas (VTR). - Stock Titan
Director Matthew J. Lustig receives 447.868 stock units instead of fees at Ventas (VTR). - Stock Titan
In lieu of director fees, Roxanne M. Martino receives 582 Ventas (VTR) stock units. - Stock Titan
Top Ventas (VTR) Competitors 2026 - MarketBeat
Ventas Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Ventas Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Ventas sets October 27 results date for Ventas stock - AD HOC NEWS
Ventas Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Ventas Inc To Go Ex-Dividend On September 30th, 2026 With 0.52 USD Dividend Per Share - Moomoo
Exchange rate effect of Ventas, Inc. – HAN:VEN - TradingView
ETFs Investing in Ventas, Inc. Stocks - TradingView
Ventas, Inc. Bonds — Corporate Bond Rates - TradingView
Is Ventas (NYSE:VTR) Facing a Real Market Test? - Kalkine Media
Ventas stock at USD 87.03 on September 28, 2026, up 0.51 percent - AD HOC NEWS
Ventas stock at USD 86.64 on September 25, 2026, down 0.22 percent - AD HOC NEWS
What's in the Offing for Ventas Stock This Earnings Season? - Eastern Progress
Ventas Announces Third Quarter 2026 Earnings Release Date and Conference Call - Business Wire
Avoiding Lag: Real-Time Signals in (VTR) Movement - news.stocktradersdaily.com
Ventas stock heads into the open after a 0.30 percent drop - ad-hoc-news.de
Andra AP fonden Acquires 106,902 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. (VTR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Why Ventas (VTR) is a Top Dividend Stock for Your Portfolio - Eastern Progress
Ventas stock gains as Evercore trims its price target - AD HOC NEWS
Ventas REIT rated buy after 4 earnings beats an... - Pluang
Ventas: Investment-Grade Senior And Outpatient REIT, A Bet On Quality And Growth (VTR) - Seeking Alpha
Ventas Inc. stock gains 0.4 percent ahead of the open - AD HOC NEWS
Baron Capital Maintains Outlook on Ventas (VTR) - news.alphastreet.com
Baron Capital Maintains Outlook on Ventas (VTR) - AlphaStreet
Ventas: Buy The Pullback As Senior Housing Boom Is Just Getting Started (NYSE:VTR) - Seeking Alpha
Despite Sale, Baron Capital Maintains Outlook on Ventas (VTR) - Yahoo Finance
Evercore ISI Adjusts Price Target on Ventas to $100 From $101, Maintains Outperform Rating - marketscreener.com
Nykredit A S Makes New Investment in Ventas, Inc. $VTR - MarketBeat
Ventas (VTR) Stock Forecast and Price Target 2026 $VTR - MarketBeat
Ventas Inc Stock (VTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ventas Inc Stock (VTR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Walter C. Rakowich | Director |
May 14 '26 |
Proposed Sale |
90.16 |
1,152 |
103,864 |
0 |
| RAKOWICH WALTER C | Director |
May 14 '26 |
Sale |
90.20 |
1,152 |
103,915 |
28,349 |
| GREGORY LIEBBE | Officer |
Mar 02 '26 |
Proposed Sale |
86.31 |
17,248 |
1,488,620 |
0 |
| Roberts Carey S. | EVP and GC |
Feb 11 '26 |
Sale |
85.00 |
35,532 |
3,020,117 |
72,755 |
| CAREY SHEA ROBERTS | Officer |
Feb 11 '26 |
Proposed Sale |
85.00 |
35,532 |
3,020,117 |
0 |
| CAFARO DEBRA A | Chairman and CEO |
Feb 06 '26 |
Option Exercise |
73.71 |
10,322 |
760,835 |
1,124,356 |
| CAFARO DEBRA A | Chairman and CEO |
Feb 06 '26 |
Sale |
82.23 |
10,322 |
848,751 |
1,114,034 |
| CAFARO DEBRA A | Officer |
Feb 06 '26 |
Proposed Sale |
82.23 |
10,322 |
848,751 |
0 |
| CAFARO DEBRA A | Chairman and CEO |
Feb 02 '26 |
Option Exercise |
73.71 |
10,322 |
760,835 |
1,124,356 |
| CAFARO DEBRA A | Chairman and CEO |
Feb 02 '26 |
Sale |
77.66 |
10,322 |
801,605 |
1,114,034 |
1.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):